Tristone Healthcare is happy to announce the successful listing of the £20,000,000 8.5% secured notes on the Cypriot Stock Exchange.
The Prospectus was approved by the Cyprus Securities and Exchange Commission (“CySEC”) as the competent authority in Cyprus which the Issuer elected as its Home Member State for the said securities. The approval only relates to the Notes which will be admitted to trading on the regulated market of the Cyprus Stock Exchange (the “CSE”) within 12 months from 8 January 2018.
The Notes will be issued to the wholesale market, to qualified investors as defined in the Investment Services and Activities and Regulated Market Law, Law 144 (I)/2007 (as amended) and Markets in Financial Investments Directive (2004/39/EC) (“MiFiD”). No Notes will be issued or offered or sold to the retail market.
For the full Prospectus (which is not for distribution within the United States) click here.